Search Results 1641-1650 of 21378 for anti-TNF drugs

1. A Study to Investigate the Effectiveness and Safety of Pf-04965842 in Subjects Aged 12 Years and Over, With Moderate to Severe Atopic Dermatitis with the Option of Rescue Treatment in Flaring Subjects - Mayo Clinic

   Herbal medications with unknown properties or known beneficial effects for AD. Within 1 week of first dose of investigational product: Anti-platelet drugs.

2. Progestin (Oral Route, Parenteral Route, Vaginal Route) Description and Brand Names - Mayo Clinic

   OHT is also called hormone replacement therapy (HRT) and estrogen replacement therapy (ERT). To treat pain that is related to endometriosis, a condition where ...

3. A Trial to Evaluate the Effectiveness, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... treatment with more than 1 oral PAH-approved therapy or any parenteral therapy. ... anti-fibrotic drug within 4 ...

4. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Stage 3 Liver Fibrosis - Mayo Clinic

   Participants taking anti-diabetic, anti-obesity, or anti-dyslipidemic medications must have been on stable regimens for at least 3 months (12 weeks) (6 ...

5. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Cirrhosis - Mayo Clinic

   Participants taking anti-diabetic, anti-obesity, or anti-dyslipidemic medications must have been on stable regimens for at least 3 months (12 weeks) (6 ...

6. Ripretinib (Oral Route) Description and Brand Names - Mayo Clinic

   Ripretinib is used to treat gastrointestinal stromal tumor (GIST) in patients who have received treatment with at least 3 other medicines (eg, imatinib).

7. Blood and Marrow Transplant Research Program - Transplant Research Center - Mayo Clinic Research

   Develop novel treatment approaches of GVHD; Test established and state-of-the-art GVHD treatment regimens, such as anti-thymocyte globulin (ATG), post ...

8. A Study to Evaluate Mutanome-directed Immunotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

   By condition, treatment or drug ... anti-PD1, anti-PDL1 or anti-CTLA4 antibodies. ... Patients under chronic treatment with systemic corticosteroids or other ...

9. A Study to Evaluate Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy for HER2+ Gastrointestinal Cancers - Mayo Clinic

   - For Cohorts 2A and 2B: prior anti-HER2 therapies - For Cohorts 1E, 1F, 1G, 2A: Prior therapy with an anti-PD-1, anti-PD-L1, or anti PD L2 agent or with an ...

10. Immune Globulin (Intramuscular Route, Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Immune globulin injection belongs to a group of medicines known as immunizing agents. ... Drugs & Supplements; Immune Globulin (Intramuscular Route, Intravenous ...